Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2350 of 3270 entries
View as:
Phase: N/A
Priority: Normal
Start: 06/01/19
End: 09/30/20
Due: 09/30/21
Phase: N/A
Priority: Normal
Start: 10/01/23
End: 01/31/25
Due: 01/31/26
Phase: N/A
Priority: Normal
Start: 12/10/12
End: 02/29/16
Due: 02/28/17
Phase: N/A
Priority: Normal
Start: 04/16/21
End: 12/31/22
Due: 12/31/23
Phase: N/A
Priority: Normal
Start: 11/30/05
End: 04/30/12
Due: 04/30/13
Phase: N/A
Priority: Normal
Start: 02/28/10
End: 06/30/12
Due: 06/30/13
Phase: N/A
Priority: Normal
Start: 03/13/20
End: 12/31/22
Due: 12/31/23
Phase: N/A
Priority: Normal
Start: 01/08/21
End: 01/26/22
Due: 01/26/23
Phase: N/A
Priority: Normal
Start: 12/31/09
End: 01/31/13
Due: 01/31/14
Phase: N/A
Priority: Normal
Start: 05/31/07
End: 05/31/09
Due: 05/31/10
Phase: N/A
Priority: Normal
Start: 10/19/23
End: 10/26/25
Due: 10/26/26
Phase: N/A
Priority: Normal
Start: 03/31/11
End: 10/31/17
Due: 10/31/18
Phase: N/A
Priority: Normal
Start: 01/19/10
End: 04/30/18
Due: 04/30/19
Phase: N/A
Priority: Normal
Start: 02/18/21
End: 02/18/22
Due: 02/18/23
Phase: N/A
Priority: Normal
Start: 09/30/10
End: 02/29/12
Due: 02/28/13
Phase: N/A
Priority: Normal
Start: 04/15/25
End: 05/01/27
Due: 05/01/28
Phase: N/A
Priority: Normal
Start: 10/31/22
End: 11/30/24
Due: 11/30/25
Phase: N/A
Priority: Normal
Start: 12/19/24
End: 12/19/26
Due: 12/19/27
Phase: N/A
Priority: Normal
Start: 12/31/09
End: 11/30/11
Due: 11/30/12
Phase: N/A
Priority: Normal
Start: 10/27/23
End: 03/31/26
Due: 03/31/27
Phase: N/A
Priority: Normal
Start: 09/30/15
End: 03/31/17
Due: 03/31/18
Phase: N/A
Priority: Normal
Start: 07/31/15
End: 01/31/16
Due: 01/31/17
Bile Acids and Gut Microbiota as Potent Coronary Atheroma Risk Factors: a Prospective Study in Human
Phase: N/A
Priority: Normal
Start: 02/28/15
End: 12/31/15
Due: 12/31/16
Phase: N/A
Priority: Normal
Start: 06/19/24
End: 05/31/28
Due: 05/31/29
Phase: N/A
Priority: Normal
Start: 02/15/17
End: 10/31/22
Due: 10/31/23